Clinical Trial Update: EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial for EnBrace HR in premenstrual syndrome and mood-related conditions was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrual Related Mood Disorder
• Premenstrual Dysphoric Disorder
• Premenstrual Syndrome
• Premenstrual Tension

Drugs mentioned

• EnBrace HR

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Premenstrual Syndrome, Premenstrual Dysphoric Disorder | Phase 4 | Status: WITHDRAWN